New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
SAB Biotherapeutics, Inc.
SABSW
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

26M

Biotechnology

0.05USD
0.00 ( 0.00%)
favorite-chart

Relative Strenght

43
favorite-chart

Volume Buzz

100%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

3%

Quote Panel

Shape
Updated October 29, 2024
1W -7.90 % 1M 39.17 % 3M 0.20 % 1Y -45.08 %

Key Metrics

Shape
  • Market Cap

    25.57M


  • Shares Outstanding

    510.28M


  • Share in Float


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    0.0501


  • Average Volume


  • Beta

    0.698


  • Range

    0.05-0.0515


  • Industry

    Biotechnology


  • Website

    http://www.sabbiotherapeutics.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

9.69x

P/S Ratio

0.59x

P/B Ratio

0.1

Debt/Equity

-1450.3%

Net Margin

$0.3

EPS

How SABSW compares to sector?

P/E Ratio

Relative Strength

Shape

SABSW

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

No Data Available

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

N/A

NA
vs NA

Q2.22

arrow
arrow

N/A

NA
vs NA

Q3.22

arrow
arrow

N/A

NA
vs NA

Q4.22

arrow
arrow

N/A

-0.18
vs NA

Q1.23

arrow
arrow

N/A

-0.15
vs NA

Q2.23

arrow
arrow

N/A

-0.14
vs NA

Q3.23

arrow
arrow

N/A

-0.10
vs NA

Q4.23

arrow
arrow

N/A

NA
vs -0.18

Q1.24

arrow
arrow

N/A

NA
vs -0.15

Q2.24

arrow
arrow

N/A

NA
vs -0.14

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

11.8M  vs NA

Q2.22

arrow
arrow

NA

6.4M  vs NA

Q3.22

arrow
arrow

NA

3.6M  vs NA

Q4.22

arrow
arrow

-96%

2.2M  vs 60.9M

Q1.23

arrow
arrow

-95%

581.1K  vs 11.8M

Q2.23

arrow
arrow

-99%

85.5K  vs 6.4M

Q3.23

arrow
arrow

-65%

1.3M  vs 3.6M

Q4.23

arrow
arrow

-86%

305K  vs 2.2M

Q1.24

arrow
arrow

+63%

944.6K  vs 581.1K

Q2.24

arrow
arrow

+208%

263.1K  vs 85.5K

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-21%

-0.21
vs -0.13

Q4.22

arrow
arrow

-25%

-0.25
vs -0.21

Q1.23

arrow
arrow

-30%

-0.30
vs -0.25

Q2.23

arrow
arrow

-35%

-0.35
vs -0.30

Q3.23

arrow
arrow

-33%

-0.33
vs -0.35

Q4.23

arrow
arrow

-40%

-0.40
vs -0.33

Q1.24

arrow
arrow

-10%

-0.10
vs -0.40

Q2.24

arrow
arrow

-16%

-0.16
vs -0.10

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

15

15
vs 15

NA

Q4.22

arrow
arrow

12

12
vs 15

-20%

Q1.23

arrow
arrow

14

14
vs 12

17%

Q2.23

arrow
arrow

11

11
vs 14

-21%

Q3.23

arrow
arrow

10

10
vs 11

-9%

Q4.23

arrow
arrow

11

11
vs 10

10%

Q1.24

arrow
arrow

12

12
vs 11

9%

Q2.24

arrow
arrow

12

12
vs 12

NA

Earnings Growth

Latest News